🏛️ Verified NIH Record • Updated 2026-01-15

SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial (NCT05831202)

🔵 Active, Not Recruiting Phase3 ⚙️ Medical Device Protocol Sponsor: Galaxy Therapeutics INC

🩺 Plain-English Summary (8th-Grade Level)

To establish the safety and effectiveness of the SEAL™ Saccular Endovascular Aneurysm Lattice system for the treatment of saccular intracranial aneurysms. The data from this study will be used to support a premarket approval (PMA) submission.

Who can join: Review the eligibility criteria below.

Location: Endeavor Health - Northwest Community Hospital — Arlington Heights, Illinois

Age range: 22 Years to 80 Years

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (6 Sites)

  • Endeavor Health - Northwest Community Hospital — Arlington Heights, Illinois
  • Endeavor Health - Evanston Hospital — Evanston, Illinois
  • Endeavor Health- Edward Hospital — Naperville, Illinois
  • The Cooper Health System — Camden, New Jersey
  • NYU Langone Health — New York, New York
  • Stony Brook University Hospital — Stony Brook, New York

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗